Idiopathic guttate hypomelanosis: Presentation and Management

Jeta Buch, Anant Patil, George Kroumpouzos, Martin Kassir, Hassan Galadari, Michael H. Gold, Mitchel P. Goldman, Stephan Grabbe, Mohamad Goldust

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)


Idiopathic guttate hypomelanosis (IGH) is a benign, typically asymptomatic, acquired leukoderma characteristically affecting mature individuals. Although the etiopathogenesis is unclear, chronic sun exposure and senile degeneration are important triggers. Researchers have been engaged in a continuous effort to unveil the gray areas encompassing different aspects of IGH pathogenesis. IGH is a clinical diagnosis; however, histopathology and dermoscopy may aid in quetionable cases. Patients often seek cosmetic treatment. There has been no standard therapy for this condition. Newer treatment modalities range from topical agents to procedure-based therapies and have enhanced the therapeutic armamentarium. Here we discuss the pathogenesis, presentation, and management of IGH.

Original languageEnglish
Pages (from-to)8-15
Number of pages8
JournalJournal of Cosmetic and Laser Therapy
Issue number1-2
Publication statusPublished - 2021


  • Idiopathic guttate hypomelanosis
  • etiology
  • management
  • treatment

ASJC Scopus subject areas

  • Surgery
  • Dermatology


Dive into the research topics of 'Idiopathic guttate hypomelanosis: Presentation and Management'. Together they form a unique fingerprint.

Cite this